Determination of pH including hemoglobin correction

• US 6,944,487 B2
• Filed: 02/25/2004
• Issued: 09/13/2005
• Est. Priority Date: 02/25/2003
• Status: Expired due to Fees

• Current Assignee: Luminous Medical, Inc.
• Original Assignee: Inlight Solutions, Inc.
• Inventors: Nunez, David, Franke, James E., Rohrscheib, Mark R., Kemeny, Gabor J., Maynard, John D., Hendee, Shonn P., Alam, M. Kathleen
• Primary Examiner(s): Winakur, Eric F.
• Assistant Examiner(s): KREMER, MATTHEW J
• Application Number:
  US10/786,662
• Publication Number:
  US 20040181131A1
• Time in Patent Office: 566 Days
• Field of Search: 600/322, 600/310, 600/320, 600/323, 600/328, 600/473, 600/475
• US Class Current: 600/322
• CPC Class Codes: A61B 5/14539 for measuring pH
• CPC Class Codes: A61B 5/14557 specially adapted to extracorporeal circuits
• CPC Class Codes: G01N 21/359 using near infrared light

Abstract

Methods and apparatuses of determining the pH of a sample. A method can comprise determining an infrared spectrum of the sample, and determining the hemoglobin concentration of the sample. The hemoglobin concentration and the infrared spectrum can then be used to determine the pH of the sample. In some embodiments, the hemoglobin concentration can be used to select an model relating infrared spectra to pH that is applicable at the determined hemoglobin concentration. In other embodiments, a model relating hemoglobin concentration and infrared spectra to pH can be used. An apparatus according to the present invention can comprise an illumination system, adapted to supply radiation to a sample; a collection system, adapted to collect radiation expressed from the sample responsive to the incident radiation; and an analysis system, adapted to relate information about the incident radiation, the expressed radiation, and the hemoglobin concentration of the sample to pH.

Claims

1. A method of determining the pH of a sample, comprising:

a) Determining an infrared spectrum of the sample;

b) Determining the concentration of hemoglobin of the sample;

c) Selecting a model relating an infrared spectrum to pH that is applicable for samples having the determined hemoglobin concentration;

d) Determining the pH of the sample from the infrared spectrum and the selected model.

2. A method as in claim 1, wherein the model comprises regression coefficients relating an infrared spectrum to sample pH.

3. A method as in claim 1, wherein the model comprises a model determined from calibration data collected from samples with hemoglobin levels spanning a range of sample hemoglobin levels.

4. A method as in claim 1, wherein the model comprises a model determined from hemoglobin-specific regression coefficients applied to calibration data collected from samples with hemoglobin levels that do not span the sample hemoglobin range.

5. A method as in claim 1, wherein determining an infrared spectrum comprises measuring the sample absorbance of infrared radiation in at least one of transmission, diffuse reflectance, transflectance, and ATR.

6. A method as in claim 1, wherein determining an infrared spectrum comprises measuring the sample absorbance of infrared radiation at a spectral resolution of 64 cm−

1 or finer.

7. A method as in claim 1, wherein determining the concentration of hemoglobin comprises at least one of:

a) Direct measurement of a blood sample using an external instrument or method and;

b) Spectroscopic measurement of a blood sample.

8. A method as in claim 1, wherein determining the concentration of hemoglobin comprises at least one of:

a) Measuring the sample hemoglobin concentration under physiological conditions that are not undergoing rapid change and;

b) Accounting for errors introduced by potentially interfering intravascular substances.

9. A method as in claim 1, wherein the sample comprises at least one of:

a) A blood sample drawn from the patient;

b) A blood sample measured intravascularly (indwelling measurement);

c) Perfused tissue;

d) Perfused skin;

e) An ex vivo blood sample in a transmission vessel;

f) An ex vivo blood sample in a transflectance vessel;

g) A blood sample in an on-line flow circuit;

h) In situ measurement of a perfused tissue; and

i) In situ measurement of a perfused organ or muscle.

10. A method of determining the pH of a sample, comprising:

a) Determining an infrared spectrum of the sample;

b) Determining the concentration of hemoglobin of the sample;

c) Selecting a model relating an infrared spectrum to pH that is applicable for samples having the determined hemoglobin concentration;

d) Determining the pH of the sample from the infrared spectrum and the selected model;

wherein determining an infrared spectrum comprises measuring the sample absorbance of infrared radiation in the spectral frequency range from 4000-11000 cm−

1.

11. A method as in claim 10, wherein determining an infrared spectrum comprises measuring the sample absorbance of infrared radiation in the spectral frequency range from 4000-8000 cm−

1.

12. A method as in claim 11, wherein determining an infrared spectrum comprises measuring the sample absorbance of infrared radiation in the spectral frequency range from 6000-6500 cm−

1.

13. A method of determining pH of a sample, comprising:

a) Determining an infrared spectrum of the sample;

b) Verifying that the spectrum is spectrally consistent with a model relating an infrared spectrum and associated hemoglobin concentration to pH;

c) Determining the concentration of hemoglobin, hematocrit, or equivalent of the sample;

d) Determining the pH of the sample from the infrared spectrum, the determined hemoglobin, hematocrit, or equivalent concentration, and the model.

14. A method as in claim 13, wherein the model comprises regression coefficients relating an infrared spectrum to sample pH.

15. A method as in claim 13, wherein the model comprises a model determined from calibration data collected from samples with hemoglobin levels spanning the range of sample hemoglobin levels.

16. A method as in claim 13, wherein the model comprises a model determined from hemoglobin-specific regression coefficients applied to calibration data collected from samples with hemoglobin levels that do not span sample hemoglobin range.

17. A method as in claim 13, wherein determining an infrared spectrum comprises measuring the sample absorbance of infrared radiation in at least one of transmission, diffuse reflectance, transflectance, ATR.

18. A method as in claim 13, wherein determining an infrared spectrum comprises measuring the sample absorbance of infrared radiation at a spectral resolution of 64 cm−

1 or finer.

19. A method as in claim 13, wherein determining the concentration of hemoglobin comprises at least one of:

a) Direct measurement of a blood sample using an external instrument or method and;

b) Spectroscopic measurement of a blood sample.

20. A method as in claim 13, wherein determining the concentration of hemoglobin comprises at least one of:

a) Measuring the sample hemoglobin concentration under physiological conditions that are not undergoing rapid change and;

b) Accounting for errors introduced by potentially interfering intravascular substances.

21. A method as in claim 13, wherein the sample comprises at least one of:

a) A blood sample drawn from the patient;

b) A blood sample measured intravascularly (indwelling measurement);

c) Perfused tissue;

d) Perfused skin;

e) An ex vivo blood sample in a transmission vessel;

f) An ex vivo blood sample in a transflectance vessel;

g) A blood sample in an on-line flow circuit;

h) In situ measurement of a perfused tissue; and

i) In situ measurement of a perfused organ or muscle.

22. A method of determining pH of a sample, comprising:

a) Determining an infrared spectrum of the sample;

b) Verifying that the spectrum is spectrally consistent with a model relating an infrared spectrum and associated hemoglobin concentration to pH;

c) Determining the concentration of hemoglobin, hematocrit, or equivalent of the sample;

d) Determining the pH of the sample from the infrared spectrum, the determined hemoglobin, hematocrit, or equivalent concentration, and the model;

wherein determining an infrared spectrum comprises measuring the sample absorbance of infrared radiation in the spectral frequency range from 4000-11000 cm−

1.

23. A method as in claim 22, wherein determining an infrared spectrum comprises measuring the sample absorbance of infrared radiation in the spectral frequency range from 4000-8000 cm−

1.

24. A method as in claim 23, wherein determining an infrared spectrum comprises measuring the sample absorbance of infrared radiation in the spectral frequency range from 6000-6500 cm−

1.

25. An apparatus for determining the pH of a sample, comprising:

a) An illumination system adapted to direct radiation to the sample;

b) A collection system adapted to receive radiation expressed from the sample responsive to incident radiation;

c) An analysis system, relating two or more of radiation expressed, incident radiation, and hemoglobin concentration to sample pH;

wherein;

d) The infrared radiation encompasses the spectral frequency range between 4000-25000 cm−

1;

e) Infrared radiation is delivered to the sample through at least one of;

optical fibers, light guides, and imaging optics;

f) Hemoglobin concentration is determined using radiation in the spectral frequency range from 10,000-25,000 cm−

1; and

g) pH is determined using radiation in the spectral frequency range from 4,000-10,000 cm−

1 combined with the hemoglobin concentration.